Julia R Dixon-Douglas Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Abstracts this author is presenting:

• CELEBRATE: A Phase 1b study to evaluate the safety, tolerability and preliminary efficacy of the Combination of Encorafenib, Binimetinib and Palbociclib in patients with BRAF-mutant metastatic melanoma (The CELEBRATE study) — Poster session 1